NEUROONE MEDICAL TECHN

NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

23 Feb 2024 14:10:00 By Nasdaq GlobeNewswire

NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

13 Feb 2024 13:00:00 By Nasdaq GlobeNewswire

NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13

08 Feb 2024 12:30:00 By Nasdaq GlobeNewswire

NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update

14 Dec 2023 13:15:00 By Nasdaq GlobeNewswire

NeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™ Ablation System

11 Dec 2023 05:00:00 By Nasdaq GlobeNewswire

NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14

07 Dec 2023 13:30:00 By Nasdaq GlobeNewswire

NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe

16 Nov 2023 05:00:00 By Nasdaq GlobeNewswire

NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

14 Nov 2023 14:15:00 By Nasdaq GlobeNewswire

NeuroOne® Provides Progress Update on FDA 510(k) Submission for OneRF™ Ablation System

07 Nov 2023 05:00:01 By Nasdaq GlobeNewswire

NeuroOne® to Present at the ThinkEquity Conference on October 19, 2023

13 Oct 2023 06:30:00 By Nasdaq GlobeNewswire

NeuroOne® to Present at the H.C. Wainwright 25th Annual Global Investment Conference

06 Sep 2023 13:00:00 By Nasdaq GlobeNewswire

NeuroOne® Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update

14 Aug 2023 13:00:00 By Nasdaq GlobeNewswire

NeuroOne® to Report Third Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on August 14

08 Aug 2023 13:00:00 By Nasdaq GlobeNewswire

NeuroOne® Submits 510(k) Application to FDA for OneRF™ Ablation System 

12 Jun 2023 05:35:00 By Nasdaq GlobeNewswire

NeuroOne® Announces First Clinical Case Using Evo® sEEG Electrode in Robotic Neurosurgery

17 May 2023 06:00:01 By Nasdaq GlobeNewswire

NeuroOne® Reports Second Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update

11 May 2023 13:00:00 By Nasdaq GlobeNewswire

NeuroOne® to Report Second Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on May 11

11 May 2023 09:17:42 By Nasdaq GlobeNewswire

NeuroOne® Announces First Clinical Case Using Evo® sEEG Electrode Performed at Mayo Clinic

10 May 2023 06:00:00 By Nasdaq GlobeNewswire

NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

05 May 2023 12:08:00 By Nasdaq GlobeNewswire

NeuroOne® to Present at the Sidoti Micro-Cap Virtual Conference on May 10

05 May 2023 06:00:00 By Nasdaq GlobeNewswire